184 related articles for article (PubMed ID: 35773413)
1. Disassembly of α6β4-mediated hemidesmosomal adhesions promotes tumorigenesis in PTEN-negative prostate cancer by targeting plectin to focal adhesions.
Wenta T; Schmidt A; Zhang Q; Devarajan R; Singh P; Yang X; Ahtikoski A; Vaarala M; Wei GH; Manninen A
Oncogene; 2022 Jul; 41(30):3804-3820. PubMed ID: 35773413
[TBL] [Abstract][Full Text] [Related]
2. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
Tan M; Xu J; Siddiqui J; Feng F; Sun Y
Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654
[TBL] [Abstract][Full Text] [Related]
3. Plectin protects podocytes from adriamycin-induced apoptosis and F-actin cytoskeletal disruption through the integrin α6β4/FAK/p38 MAPK pathway.
Ni Y; Wang X; Yin X; Li Y; Liu X; Wang H; Liu X; Zhang J; Gao H; Shi B; Zhao S
J Cell Mol Med; 2018 Nov; 22(11):5450-5467. PubMed ID: 30187999
[TBL] [Abstract][Full Text] [Related]
4. Integrin α6β4 requires plectin and vimentin for adhesion complex distribution and invasive growth.
Qi L; Knifley T; Chen M; O'Connor KL
J Cell Sci; 2022 Jan; 135(2):. PubMed ID: 34897465
[TBL] [Abstract][Full Text] [Related]
5. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
[TBL] [Abstract][Full Text] [Related]
6. Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance.
Sakamoto S; McCann RO; Dhir R; Kyprianou N
Cancer Res; 2010 Mar; 70(5):1885-95. PubMed ID: 20160039
[TBL] [Abstract][Full Text] [Related]
7. RUNX2 overexpression and PTEN haploinsufficiency cooperate to promote CXCR7 expression and cellular trafficking, AKT hyperactivation and prostate tumorigenesis.
Bai Y; Yang Y; Yan Y; Zhong J; Blee AM; Pan Y; Ma T; Karnes RJ; Jimenez R; Xu W; Huang H
Theranostics; 2019; 9(12):3459-3475. PubMed ID: 31281490
[No Abstract] [Full Text] [Related]
8. KDM5B Is Essential for the Hyperactivation of PI3K/AKT Signaling in Prostate Tumorigenesis.
Li G; Kanagasabai T; Lu W; Zou MR; Zhang SM; Celada SI; Izban MG; Liu Q; Lu T; Ballard BR; Zhou X; Adunyah SE; Matusik RJ; Yan Q; Chen Z
Cancer Res; 2020 Nov; 80(21):4633-4643. PubMed ID: 32868382
[TBL] [Abstract][Full Text] [Related]
9. The pace of prostatic intraepithelial neoplasia development is determined by the timing of Pten tumor suppressor gene excision.
Luchman HA; Benediktsson H; Villemaire ML; Peterson AC; Jirik FR
PLoS One; 2008; 3(12):e3940. PubMed ID: 19081794
[TBL] [Abstract][Full Text] [Related]
10. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
11. Interplay Among PI3K/AKT, PTEN/FOXO and AR Signaling in Prostate Cancer.
Yan Y; Huang H
Adv Exp Med Biol; 2019; 1210():319-331. PubMed ID: 31900915
[TBL] [Abstract][Full Text] [Related]
12. Novel pharmacologic targeting of tight junctions and focal adhesions in prostate cancer cells.
Hensley PJ; Desiniotis A; Wang C; Stromberg A; Chen CS; Kyprianou N
PLoS One; 2014; 9(1):e86238. PubMed ID: 24497940
[TBL] [Abstract][Full Text] [Related]
13. Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines.
Festuccia C; Muzi P; Millimaggi D; Biordi L; Gravina GL; Speca S; Angelucci A; Dolo V; Vicentini C; Bologna M
Endocr Relat Cancer; 2005 Dec; 12(4):983-98. PubMed ID: 16322337
[TBL] [Abstract][Full Text] [Related]
14. Plectin isoform-dependent regulation of keratin-integrin alpha6beta4 anchorage via Ca2+/calmodulin.
Kostan J; Gregor M; Walko G; Wiche G
J Biol Chem; 2009 Jul; 284(27):18525-36. PubMed ID: 19419971
[TBL] [Abstract][Full Text] [Related]
15. Synthetic Lethality in PTEN-Mutant Prostate Cancer Is Induced by Combinatorial PI3K/Akt and BCL-XL Inhibition.
Ren W; Joshi R; Mathew P
Mol Cancer Res; 2016 Dec; 14(12):1176-1181. PubMed ID: 27590631
[TBL] [Abstract][Full Text] [Related]
16. Loss of α6β4 Integrin-Mediated Hemidesmosomes Promotes Prostate Epithelial Cell Migration by Stimulating Focal Adhesion Dynamics.
Schmidt A; Kaakinen M; Wenta T; Manninen A
Front Cell Dev Biol; 2022; 10():886569. PubMed ID: 35874837
[TBL] [Abstract][Full Text] [Related]
17. SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma.
Yu C; Zhang B; Li YL; Yu XR
Biomed Pharmacother; 2018 Sep; 105():10-17. PubMed ID: 29807230
[TBL] [Abstract][Full Text] [Related]
18. Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT.
Zheng Y; Gierut J; Wang Z; Miao J; Asara JM; Tyner AL
Oncogene; 2013 Sep; 32(36):4304-12. PubMed ID: 23027128
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic ERG Represses PI3K Signaling through Downregulation of IRS2.
Mao N; Gao D; Hu W; Gadal S; Hieronymus H; Wang S; Lee YS; Sullivan P; Zhang Z; Choi D; Rosen N; Sawyers CL; Gopalan A; Chen Y; Carver BS
Cancer Res; 2020 Apr; 80(7):1428-1437. PubMed ID: 32015092
[TBL] [Abstract][Full Text] [Related]
20. Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells.
Chetram MA; Odero-Marah V; Hinton CV
Mol Cancer Res; 2011 Jan; 9(1):90-102. PubMed ID: 21076047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
